Cesar Castro, MD
Cesar Castro, MD
About Cesar Castro, MD
Departments, Centers, & Programs:
Clinical Interests:
- Ovarian cancer
- Uterine cancer
- Cervical cancer
- Novel targeted agents and personalized therapy
- Nanomedicine
- Clinical trials
Treats:
- Adult
Locations
Hematology/Oncology
55 Fruit Street
Boston, MA 02114-2696
Phone: 617-724-4000
Medical Education
- MD, UC San Francisco School of Medicine
- University of California @ San Francisco & UC-Berkeley Joint Medical Program
- Residency, UC - San Francisco Medical Center
- Residency, UC San Francisco
- Fellowship, Dana Farber Cancer Institute
American Board Certifications
- Medical Oncology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna Health Inc.
- AllWays Health (NHP) - ACD
- AllWays Health (NHP) - PBO
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna (PAL #'s)
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- MassHealth
- Medicare
- Medicare - ACD
- Medicare - NH
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Railroad Medicare
- Railroad Medicare - ACD
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
My research endeavors seek to bridge advances in novel technologies and therapeutics with current clinical oncology needs. Prior formal intensive training in biomedical research design at the UC Berkeley School of Public Health and at the National Institutes of Health places me in a unique position to translate advances in the lab to the bedside. Moreover, I have broadened my skill set in clinical investigation by completing the Scholars in Clinical Science Program, a two year structured training curriculum that led to a Master of Medical Sciences from Harvard Medical School. I also completed a clinical fellowship in Oncology through the Dana-Farber / Mass General Brigham Cancer Care Program. This breadth of clinical training exposed me to the day to day quandaries across the spectrum of solid and hematological tumors. Previously, I was involved with nanotechnology research at the National Cancer Institute where I truly first appreciated the meaning of interdisciplinary. I continue the spirit of this approach as Director of the Cancer Program within the MGH Center for Systems Biology. I am now poised to ask further challenging clinical questions in need of innovative solutions. My objectives are to refine and translate novel molecular imaging and nanosensing tactics into solid tumors. My efforts have led to inroads into point-of-care diagnostic solutions for resource-constrained regions globally. My daily research interactions involve an amalgam of chemists, material scientists, engineers, and clinicians as we continue to strive for interdisciplinary, innovative solutions to tackle biological problems plaguing cancer researchers.
Patient Gateway
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
2021 Virtual Survivorship Conference
Join us for this free webinar series. We welcome anyone living with, through, and beyond cancer and their family members and friends.
#1 Research Hospital in America
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.